Cancer Chemotherapy, Bioactive Compounds, and Immunotherapy

2021 ◽  
pp. 45-87
Author(s):  
Eva Fischer-Fodor ◽  
Anna Andreea Zimta ◽  
Mihail Buse ◽  
Ioana Berindan Neagoe
2017 ◽  
Vol 8 ◽  
Author(s):  
Saúl Redondo-Blanco ◽  
Javier Fernández ◽  
Ignacio Gutiérrez-del-Río ◽  
Claudio J. Villar ◽  
Felipe Lombó

2020 ◽  
Vol 20 (9) ◽  
pp. 726-738
Author(s):  
Elie Hembe Mukaya ◽  
Xavier Yangkou Mbianda

Among the methods used for the treatment of cancer, chemotherapy is widely used, and it is by far one of the most unpleasant procedures given to a patient because of its severe side effects; while being necessary. One of the major problems in cancer chemotherapy is the limited selectivity of most of the drugs in current clinical use. Following administration, the active agent is distributed over the entire body and reaches not only the target cells or tissues but also interacts with healthy cells. In an attempt to overcome the side effects of anticancer drugs, the modification of the anticancer bioactive compounds has been a topic of active research for years. Numerous delivery systems such as drugcontaining liposomes, microencapsulation, nanoparticles, and water-soluble polymers have been used for the delivery of bioactive compounds to the site of action. Water-soluble polymeric conjugates and co-conjugates have remained the most outstanding delivery technique. This review will discuss the development of polymeric conjugates and co-conjugates of ferrocene in cancer research.


Planta Medica ◽  
2009 ◽  
Vol 75 (09) ◽  
Author(s):  
B Biloa Messi ◽  
R Ho ◽  
A Meli Lannang ◽  
JG Tangmouo ◽  
A Marston ◽  
...  
Keyword(s):  

Planta Medica ◽  
2012 ◽  
Vol 78 (05) ◽  
Author(s):  
L Bohlin ◽  
C Alsmark ◽  
U Göransson ◽  
M Klum ◽  
C Wedén ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document